Derivatives of 17-phenyl-18,19,20-trinorprostaglandin F2 alpha isopropyl ester: potential antiglaucoma agents.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1995-01-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00002A011PMID 7830272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.

  1993cited by this paper
• Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study.

  1993cited by this paper
• Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents.

  1993cited by this paper
• The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.

  1993cited by this paper
• Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes.

  1989cited by this paper
• Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey.

  1989cited by this paper
• Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.

  1989cited by this paper
• Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma.

  1989cited by this paper
• Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.

  1989cited by this paper
• Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha.

  1987cited by this paper
• The effects of prostaglandin F2 alpha in the human eye.

  1985cited by this paper
• Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes.

  1983cited by this paper
• Comparison of the hypotensive and other ocular effects of prostaglandins E2 and F2 alpha on cat and rhesus monkey eyes.

  1982cited by this paper
• Efficient generation of the 15S configuration in prostaglandin synthesis. Attractive interactions in stereochemical control of carbonyl reduction.

  1972cited by this paper
• New reagents for stereoselective carbonyl reduction. An improved synthetic route to the primary prostaglandins.

  1971cited by this paper

• Chemoreactome analysis of methylethylpyridinol and possible mechanisms of ophthalmoprotection

  2025cites this paper
• Prostanoid receptors in GtoPdb v.2025.3

  2025cites this paper
• Compounds targeting multiple prostanoid receptors

  2021cites this paper
• Prostanoid receptors in GtoPdb v.2021.2

  2021cites this paper
• Total synthesis and conformational study of ovalifoliolatin B

  2020cites this paper
• Prostanoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595

  2019cites this paper
• A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost

  2017cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• DEVELOPMENT OF STABLE LATANOPROST OPHTHALMIC COMPOSITION USING

  2013cites this paper
• Therapeutic uses of prostaglandin F(2α) analogues in ocular disease and novel synthetic strategies.

  2013cites this paper
• IJPRBS 403

  2013influential citation
• A novel convergent synthesis of the potent antiglaucoma agent travoprost

  2013cites this paper
• A novel convergent synthesis of the antiglaucoma PGF2α analogue bimatoprost.

  2013cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• Agents Acting on Prostanoid and Thromboxane Receptors

  2010cites this paper
• Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: synthesis and biological activity.

  2009cites this paper
• Update and commentary on the pro-drug bimatoprost and a putative ‘prostamide receptor’

  2009cites this paper
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cites this paper
• Molecular design for enhancement of ocular penetration.

  2008cites this paper
• Cat Iris Sphincter Smooth-Muscle Contraction: Comparison of FP-Class Prostaglandin Analog Agonist Activities

  2008cites this paper
• Recent Renaissance of Prostaglandin Research

  2008cites this paper
• Prodrug approaches to ophthalmic drug delivery

  2007cites this paper
• Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision).

  2007cites this paper
• Recent developments in the synthesis of prostaglandins and analogues.

  2007cites this paper
• Ionic liquid-promoted, highly regioselective Heck arylation of electron-rich olefins by aryl halides.

  2005cites this paper
• Stability of latanoprost in an ophthalmic lipid emulsion using polyvinyl alcohol.

  2005cites this paper
• Guide to Receptors and Channels, 1st Edition

  2004cites this paper
• Ocular Hypotensive FP Prostaglandin (PG) Analogs: PG Receptor Subtype Binding Affinities and Selectivities, and Agonist Potencies at FP and Other PG Receptors in Cultured Cells

  2003cites this paper
• Human Ciliary Muscle Cell Responses to FP-Class Prostaglandin Analogs: Phosphoinositide Hydrolysis, Intracellular Ca2+ Mobilization and MAP Kinase Activation

  2003cites this paper
• Bimatoprost vs. timolol.

  2002cites this paper
• Palladium catalysed regioselective arylation of electron-rich olefins by aryl halides

  2002cites this paper
• Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.

  2002cites this paper
• Effect of Temperature and Light on the Stability of Latanoprost and its Clinical Relevance

  2001cites this paper
• From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.

  2001cites this paper
• Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis.

  2001cites this paper
• Synthesis and biological activity of a novel 11a-homo (cyclohexyl) prostaglandin.

  2000cites this paper
• Design and synthesis of 13,14-dihydro prostaglandin F(1alpha) analogues as potent and selective ligands for the human FP receptor.

  2000cites this paper
• Synthesis and structure-activity relationships of new 1, 3-disubstituted cyclohexanes as structurally rigid leukotriene B(4) receptor antagonists.

  1999cites this paper
• Regio- and Stereoselective Reactions of 17-Phenyl-18,19,20-trinorprostaglandin F(2)(alpha) Isopropyl Ester.

  1996cites this paper
• Study on Efficient Synthetic Routes for 7-Fluoroprostaglandin F2α and 7-Fluoro-17,20-dimethyl-2,4-methyleneprostacyclin

  1996cites this paper
• Prodrugs for improved ocular drug delivery

  1996cites this paper
• Section Review Cardiovascular & Renal Glaucoma: novel agents and recent therapeutic advances

  1996cites this paper
• Ligand-controlled palladium-catalyzed intramolecular reactions of phenyl-substituted prostaglandin F2α analogues

  1995cites this paper